Patients
Biosimilars: Unlocking access, closing the cost divide
… the gap for good There's no shortage of interest in fixing …
214 items found
News
Novo Nordisk unleashes Wegovy telehealth blitz
… drug is no longer on the FDA shortage list. A huge market for …
News
First gene-edited pig liver transplant 'worked for 10 days'
… the problem of a worldwide shortage of human donors. Pigs are …
News
Novo Nordisk follows Lilly into DTC obesity drug market
… in Wegovy – from the FDA's shortage list and comes a few … drugs now officially off the shortage list, the clock has …
News
Lilly uses Oscars ad to warn about 'untested' GLP-1s
… Appearing on the FDA's shortage list opened the door for …
News
AI tool detects brain lesions linked to epilepsy
… the US – in how to use it. Drug shortage problem The potential of …
News
Compounders cast adrift after semaglutide shortage ends
… has said there is no longer a shortage in the US market for Novo … a brandname drug on the FDA shortage list can be made …
R&D
Will 2025 be the year the pharmaceutical industry finds its feet?
… strings. Meanwhile, there is no shortage of great science and …
News
Pharma group slams Hims & Hers over Super Bowl GLP-1 ad
… the drug appears on the FDA's shortage list, which opens the … resort for patients during a shortage and should never be the …
News
Novo rises on Wegovy sales leap, but warns of a slowdown
… constraints and related drug shortage notifications across a …
News
Lilly nets Scorpion cancer drug in $2.5bn licensing deal
… set up Scorpion. There's no shortage of other candidates …
News
Novo Nordisk asks FDA not to allow GLP-1 compounding
… – for example, if there is a shortage in the marketplace. Some …
News
Apogee rises as long-acting eczema drug heads for phase 3
Apogee shares have spiked on data showing strong efficacy with its atopic dermatitis drug and the potential for dosing just two to four times a year.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
On the forefront of healthcare change, turning innovative sc...
Claus Zieler, chief commercial and medical affairs officer & member of the Executive Committee at Astellas Pharma, spoke with pharmaphorum at ASCO25.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
Partner Content
16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This